ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 602850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 602850; 2) Community: the network communities that were significantly associated with the response to NSC 602850; 3) Molecule: the relationships between components within communities and NSC 602850; 4) MDR: the compounds that were significantly associated with the NSC 602850.

NSC Compound Enrichment Correlation
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00862782236704185 0.30812848
NSC 727286 6-(bromomethyl)-1,4-anthracenedione. 0.00862782236704185 0.52300588
NSC 727486 Null 0.00862782236704185 -0.082047585
NSC 753790 6-Imino-1,2,3,4,8,9,10,11-octahydropyrido[1,2-a]pyrido[1',2',1,2]imidazo[5,4-f]benzimidazol-13-one 0.00862782236704185 -0.32206469
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.00862782236704185 0.4566308
NSC 150446 Berberine iodide 0.00896740831404549 -0.015813572
NSC 33419 1,3-Diamino-5-methylphenazinium chloride 0.00896740831404549 -0.10432406
NSC 609397 B817373K328 0.00896740831404568 -0.018119723
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.00896740831404568 0.57981872
NSC 725048 2-[3-Chloro-3-(4-chloro-phenyl)-allylidene]-malononitrile 0.00896740831404568 0.47649834
Total:60  Current:11    [First] [Prev] [Next] [Last]